chapter 20 ; cancer; overview, proto-oncs, TSG Flashcards
(42 cards)
describe a benign tumor
still responds to cell signaling properly, not deadly, but can be fatal in the brain
describe a malignant tumor
loss of cell adhesion and communication, can invade and disrupt tissues
what type of proteins cause cells to leave area and metastasize if they are mutated?
cohesion proteins
old belief of cancer
it was believed that humans lost genes due to a mutation, which allowed fast unregulated growth, lost adhesion, and signal recognition
* rare event that a cell had such mutations and accumulated over time
actual occurrence of cancer
- a cell loses ability to complete regulated growth, cell adhesion and recognition
-immune system misses the cell and it continues to reproduce.
give an overview of b cells working in the immune system
- the immune system can recognize cancer cells
- b cells are made in the bone marrow and is exposed to all proteins made in the body, has the chance to stick, the combination makes a dead b cell.
- b cells that don’t stick are released to the body this eliminates cells that stick to our own proteins.
cells have TSA’s and TAA’s, describe them
TSA: tumor specific antigen. proteins produced on a cancer cell that other cells do not have. due to fetal development genes. b cells are unfamiliar and bind to them
TAA: tumor-associated antigen, proteins that can be recognized, associated at an elevated level.
the cell cycle has ________, that trigger progression into the next phase, turns on genes
CDK- cyclin complexes, checkpoints
Cyclin
proteins made in large numbers and are quickly degraded
CDK
cyclin dependent kinases, an enzyme
Cyclin-CDK
: complexes, phosphorylate proteins
G1 Cyclin CDK
activates and turn on genes that make ligase, polymerase, etc
in cancer cells which phases of the cell cycle are short and effect proto-oncogenes and tumor suppressor genes?
Phases G1 and G2
cancer traits
- some cancers are hereditary: 10%
- sporadic cancer: not inherited, more common, start from ones own cell. 90%
- some viruses can induce cancer: called retrovirus. start as RNA revert back to DNA and inserted into chromosome. they tend to have lytic and latent phase. if they dont have a latent phase they tend to kill the cell they are in which does not cause cancer
-descendants of cancerous cells are all cancerous, don’t revert back
-can increase the risk of cancer through exposure of mutagens, mutation rate is increased. mutations drive cancer
-certain chromosomal mutations are associated with particular forms of cancer. chromosome 17 has BRACA-2 and chromosome 13 has BRACA 1
healthy cells vs tumor cells
healthy cells: need factors that stimulate and also prevent growth
tumor cells: dont regulate, shorten G1 and G2.
-lose genes to a mutation, not cancerous yet
-replicates and mass-produces
-as a tumor gets larger it has a lot of cells that lost function and further accumulate more mutations
-more mutations cause a higher risk of cancer.
what are the types of cancer genes?
-proto-oncogenes to oncogenes
-tumor suppressor genes
-miRNA genes
-mutator genes
briefly describe proto-oncogenes
proteins produced by these genes move the cell cycle forward, function normally. can be modified into oncogens, they function in a dominant way, only a single copy of the gene can lead to an imbalance in cell regulation
-ex. RAS, Src, C-oncs, V-oncs
-RAS: g coupling protein
-Src: tyrosine kinase
-C-oncs: chromosomal: Src, RAS, CDKs
-V-onc: viral genes that move cell cycle forward
describe oncogenes
mutated proto oncogene, functions without regulation too well, more active than normal or at inappropriate times. function in a dominant manner, only need 1 gene to increase risk.
briefly describe tumor suppressor genes
proteins produced by the gene promote slowed or paused cell cycles
ex. p53, p14, pRB
-mutations act in a recessive fashion, both mom and dads need to be mutated
briefly describe miRNA gene
play an important role in RISC formation and can act as either proto-oncogenes or tumor suppressor genes
ex. Let-7 miRNA and mi373/372
briefly describe mutator genes
proteins produced by these genes repair damaged DNA. with such repairs all the other cancer genes have a greater chance of not functioning properly.
-includes BRACA 1 and 2, UvR system, mutation repair exam 2 material.
-act more as TSG; revert DNA to normal state
-if you lose ability to fix genes, you begin to accumulate more mutations, more likely to damage proto-oncs and TSGs
-when they work properly they help prevent cancer
-both need to be broken to cause issues
describe the proto-oncogene signal transduction pathway
*overall involves positive control of cell growth, products that stimulate growth or are present in the pathway
-stimulus and binding of a hormone to receptor activates SRC
-Src: membrane associated non-receptor protein tyrosine kinase, kinase can phosphorylate other proteins, quickly interacts with g coupling protein RAS
-RAS: g coupling protein, once activated converts GTP to GDP, then activates adenyl cyclase, need high levels
-Adenylyl Cyclase: enzyme, converts ATP to cyclic AMP.
-cAMP: interacts with protein kinase A, dislodge and phosphorylates protein kinase A
-protein kinase A: becomes activated, enters nucleus and phosphorylates activator proteins
-activator proteins: turn on gene for cyclins
-cyclins: build up and bind to CDK’s
-CDK: once activated, phosphorylate pRB
-pRB: regulates at G1-S. found with E2F
Tumor suppressor genes: Retinoblastoma
-type of cancer, takes two mutated gene, helps understand sporadic and hereditary cancers
-hereditary: mutation, inherit from mom and a bad mutated version. sperm hits egg, that particular cell has a bad and good version of gene, leads to every cell inheriting the bad version.mutation is present in 70 trillion cells, any one cell gets 2nd mutation which makes it cancerous
-sporadic: 90%, many cells lead to a large chance of one type cancer to come up. after you are born you get the same mutation, every cell has the mutation. need to hit the same cell for it to become cancerous
describe pRB and its interactions with E2F:
pRB: protein retinoblastoma , involved at G1-s checkpoint, found in complex with E2F
-unphosphorylated: inhibits transcription factor E2F, functions as TSG= slows
-phosphorylated: inhibition of E2F is removed and the transcription factor turns on transcription for DNA synthesis.
-E2F: activator for proteins that copy DNA (helicase, ligase), cell cycle moves forward S phase.